https://www.marketscreener.com/quote/stock/TERNS-PHARMACEUTICALS-INC-118621672/news/Terns-Announces-Initiation-of-Patient-Dosing-in-AVIATION-Phase-1b-NASH-Clinical-Trial-of-VAP-1-Inhib-35699499/?utm_source=telegram&utm_medium=social&utm_campaign=share